日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CT perfusion ischemic core predicts PH-2 hemorrhagic transformation following intravenous alteplase bridging treatment prior to endovascular thrombectomy

CT灌注缺血核心可预测静脉注射阿替普酶桥接治疗后行血管内血栓切除术后的PH-2出血性转化

Honig, Asaf; Alpernas, Aviva; Schwartzmann, Yoel; Hallevi, Hen; Metanis, Issa; Ben-Assayag, Einor; Jonas-Kimchi, Tali; Sadeh, Udi; Jubran, Hamza; Haim, Oz; Cohen, Jose; Leker, Ronen R; Molad, Jeremy

Association of CT perfusion parameters with outcomes in patients with medium vessel occlusion undergoing endovascular thrombectomy

CT灌注参数与接受血管内血栓切除术的中等血管闭塞患者预后的相关性

Schwartzmann, Yoel; Joubran, Hamza; Jubeh, Tamer; Metanis, Issa; Alpernas, Aviva; Jonas-Kimchi, Tali; Sadeh, Udi; Gomori, John M; Cohen, Jose E; Hallevi, Hen; Molad, Jeremy; Leker, Ronen R

Post-Stroke PTSD: The Protective Role of CCR5-Δ32 Polymorphism

中风后创伤后应激障碍:CCR5-Δ32多态性的保护作用

Hallevi, Hen; Tene, Oren; Molad, Jeremy; Alpernas, Aviva; Niry, Dana; Usher, Saly; Feldinger, Lital; Seyman, Estelle; Ben Assayag, Einor

Blocking CCR5 activity by maraviroc augmentation in post-stroke depression: a proof-of-concept clinical trial

通过马拉维罗增强治疗阻断 CCR5 活性来治疗卒中后抑郁症:一项概念验证性临床试验

Tene, Oren; Molad, Jeremy; Rotschild, Ofer; Alpernas, Aviva; Hawwari, Muhamad; Seyman, Estelle; Giladi, Nir; Hallevi, Hen; Assayag, Einor Ben

Preventing post-stroke dementia. The MARCH Trial. Protocol and statistical analysis plan of a randomized clinical trial testing the safety and efficacy of Maraviroc in post-stroke cognitive impairment

预防卒中后痴呆:MARCH试验。一项随机临床试验的方案和统计分析计划,旨在检验马拉维罗克治疗卒中后认知障碍的安全性和有效性。

Assayag, Einor Ben; Molad, Jeremy; Seyman, Estelle; Rotschild, Ofer; Zeltzer, Ehud; Sadeh-Gonik, Udi; Bregman, Noa; Alpernas, Aviva; Segal, Yahel; Bashat, Dafna Ben; Nathan, Talya; Hawwari, Muhamad; Tene, Oren; Hallevi, Hen